The main risk is not basic reactor feasibility but commercial conversion. NuScale has a rare licensing asset, strong liquidity, and real supply-readiness progress, yet the stock only compounds if partner-led projects become binding, funded, and executable before
dilution, pricing caps, or regulatory lag leave it as a thin engineering vendor.